Dr. Gary Kirsh, a veteran physician executive who spent decades building the nation's largest urology management services organization, has been appointed chief executive officer of Cardiovascular Logistics, effective immediately. The 49-year-old cardiologist platform, backed by private equity firm Lee Equity Partners, announced the appointment on Monday. David Konur, who founded CVL in partnership with Lee Equity in 2023 and previously served 24 years as CEO of Cardiovascular Institute of the South, transitions to chairman of CVL's board.
Kirsh brings proven expertise in scaling physician-led specialty platforms. As co-founder and former CEO of Solaris Health, he assembled a network of over 1,000 providers across more than 250 practice locations in 14 states. In November 2025, Cardinal Health acquired Solaris Health for approximately $2.4 billion, incorporating it into The Specialty Alliance, its multispecialty management services organization. Upon that transaction's completion, Kirsh stepped down as CEO and joined Cardinal Health as a senior advisor. He has served on CVL's board since November 2025. Konur said in the announcement that he has "the utmost confidence in Dr. Gary Kirsh and our executive team to lead CVL in the next phase of its growth as we fundamentally change how cardiovascular care is delivered in our country."
Kirsh is a practicing urologist with three decades of clinical experience and a nationally recognized advocate for independent, physician-led medicine. He is a founder and former president of the Large Urology Group Practice Association, the national trade association for independent urology practices, and previously served as president of the American Association of Clinical Urologists, the North Central Section of the American Urological Association, and the Ohio Urologic Society. He has testified before state legislatures and Congress on healthcare policy matters. In his new role, Kirsh emphasizes CVL's distinctive market position: "CVL has built something rare in healthcare, a national platform of premier cardiology practices that have come together without losing what makes each of them exceptional."
Cardiovascular Logistics operates as one of the nation's leading cardiology management services organizations with approximately 440 providers across multiple states, supported by a network of premier practices including Cardiovascular Institute of the South, First Coast Cardiovascular Institute, Capital Cardiology Associates, and Clearwater Cardiovascular Consultants. CVL was formed in January 2023 through a partnership between CIS, one of the largest independent cardiovascular practices in the country, and Lee Equity Partners, a New York-based private equity firm specializing in healthcare and financial services. The platform has expanded through multiple practice acquisitions and now serves multiple states with comprehensive cardiac, vascular, and electrophysiology services. Lee Equity Partners targets investments of $50 million to $150 million in middle-market companies and has built a portfolio of healthcare, financial services, and business services companies over two decades.
Kirsh's appointment signals CVL's growth ambitions in a consolidating healthcare landscape. The cardiology management services sector has seen increasing deal activity as independent practices face operational pressures and seek scale. Kirsh's track record building Solaris Health into a dominant urology platform suggests CVL's board believes he can execute a similar strategy in cardiology, particularly as cardiovascular disease remains the leading cause of death in the United States. His subsequent role as senior advisor to Cardinal Health provided exposure to large-scale healthcare operations and integration dynamics. The CEO transition also reflects Konur's strategic pivot; as chairman, he will focus on CVL's strategy, key industry relationships, and acquisition opportunities while advising Lee Equity on broader healthcare services sector investments. This division of responsibilities between operational leadership and board-level strategy is typical of private equity-backed healthcare platforms navigating aggressive expansion targets.
